Prelude Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Sell |
33,422
-4,278
| -11% | -$14.7K | 0.01% | 881 |
|
|
2025
Q1 | $112K | Buy |
37,700
+12,900
| +52% | +$38.2K | 0.01% | 938 |
|
|
2024
Q4 | $75.6K | Buy |
+24,800
| New | +$75.6K | ﹤0.01% | 992 |
|
|
2019
Q3 | – | Sell |
-120
| Closed | -$2K | – | 1473 |
|
|
2019
Q2 | $2K | Sell |
120
-280
| -70% | -$4.67K | ﹤0.01% | 1167 |
|
|
2019
Q1 | $16K | Hold |
400
| – | – | ﹤0.01% | 979 |
|
|
2018
Q4 | $8K | Buy |
+400
| New | +$8K | ﹤0.01% | 1073 |
|
|
2018
Q2 | – | Sell |
-8,723
| Closed | -$594K | – | 1578 |
|
|
2018
Q1 | $594K | Sell |
8,723
-3,636
| -29% | -$248K | 0.04% | 346 |
|
|
2017
Q4 | $1.22M | Buy |
+12,359
| New | +$1.22M | 0.1% | 179 |
|
|
2017
Q2 | – | Sell |
-20,335
| Closed | -$756K | – | 1676 |
|
|
2017
Q1 | $756K | Buy |
+20,335
| New | +$756K | 0.07% | 249 |
|
|
2015
Q3 | – | Sell |
-1,689
| Closed | -$197K | – | 1617 |
|
|
2015
Q2 | $197K | Hold |
1,689
| – | – | 0.03% | 553 |
|
|
2015
Q1 | $399K | Buy |
+1,689
| New | +$399K | 0.06% | 392 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1982 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 1931 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 1895 |
|